This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: bariatric surgery

August 2018 Br J Cardiol 2018;25:95

HEART UK – Hot topics in atherosclerosis and cardiovascular disease

Jaqui Walker

Abstract

Professor Klaus Parhofer Lipoprotein (a) The role of lipoprotein (a) [Lp(a)] was explored by Professor Klaus Parhofer (Ludwig Maximilians University, Munich, Germany). This is an independent risk factor in cardiovascular disease (CVD), with a causal link to atherosclerosis, myocardial infarction (MI), aortic valve stenosis and heart failure. Of the different therapies that can be used to reduce elevated Lp(a), only apheresis shows a reduction in CVD events. Currently, the most important management strategy is to optimise all other CVD risk factors, particularly low-density-lipoprotein cholesterol (LDL-C). In patients with progressive CVD, de

| Full text
In brief

June 2014 Br J Cardiol 2014;21:58

In brief

BJCardio Staff

Abstract

NICE draft guidance on acute heart failure published The draft acute heart failure clinical guideline from the National Institute of Health and Care Excellence (NICE) is now out for consultation with stakeholders. Guideline recommendations, available on http://www.nice.org.uk, include advice that people with suspected acute heart failure should be seen by a specialist team with a heart failure service at hospital. Currently practice is not standardised across hospitals and many patients are not treated by a dedicated service. …and also on ICDs and CRT   Draft technology appraisal guidance on the most clinically and cost-effective impla

| Full text
News from ACC.14

April 2014 Br J Cardiol 2014;21:56–7 Online First

News from ACC.14

BJCardio Staff

Abstract

HEAT-PPCI: heparin outperforms bivalirudin in primary PCI The major talking point of this year’s American College of Cardiology meeting was without doubt the aptly named HEAT-PPCI trial which generated more heat than has been seen at such conferences for quite some time. The trial acronym stands for How Effective Are Antithrombotic Therapies in Primary PCI (percutaneous coronary intervention), and the study – conducted in the UK under the leadership of Dr Rod Stables (Liverpool Heart and Chest Hospital) – compared unfractionated heparin with bivalirudin (Angiomax®, the Medicines Company) in patients with ST-elevation myoca

| Full text
News from the American College of Cardiology Scientific Session 2012

May 2012 Br J Cardiol 2012;19:59–61

News from the American College of Cardiology Scientific Session 2012

News from the world of cardiology

Abstract

CORONARY: off-pump and on-pump CABG similar The largest trial ever to compare off-pump and on-pump coronary artery bypass surgery (CABG) has shown no difference between the two techniques in terms of the primary composite end point. There were, however, some differences in certain end points, leading to the suggestion that the decision as to which approach to choose could be individualised with each patient. Table 1. Main results from the CORONARY trial The CORONARY trial enrolled 4,752 patients who were randomised to off-pump or on-pump surgery. At 30 days the primary end point – a composite of death, myocardial infraction (MI), kidney fai

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now